Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 7/20 | 0.34 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | ITGB2 | P05107 | 2/20 | 0.30 |
| ▸ | ICAM1 | P05362 | 2/20 | 0.30 |
| ▸ | ITGAL | P20701 | 2/20 | 0.30 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.30 |
| ▸ | ACACB | O00763 | 1/20 | 0.30 |
| ▸ | CPB1 | P15086 | 1/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6564177 | 1.00 | TGM2 (0.34) | TGM2GSTO1TSHRPPARGCYP2C19 | |
| Hydrochloric Acid SCHEMBL28591530 | 0.99 | TGM2 (0.33) | TGM2GSTO1TSHRPPARGCYP2C19 | |
| SCHEMBL5154061 | 0.86 | GSTO1 (0.31) | TGM2GSTO1 | |
| SCHEMBL5154074 | 0.86 | GSTO1 (0.31) | TGM2GSTO1 | |
| SCHEMBL28309350 | 0.85 | NOS2 (0.37) | TGM2TSHRPPARGNOS2ACACB | |
| SCHEMBL30155062 | 0.85 | TAAR1 (0.39) | PPARGCYP2C19NOS2ALOX15ITGB2 | |
| SCHEMBL1073717 | 0.84 | ITGB2 (0.36) | ITGB2ICAM1ITGALCPB2CPB1 | |
| SCHEMBL5893971 | 0.83 | CPB2 (0.32) | CPB2CPB1 | |
| SCHEMBL5893967 | 0.83 | CPB2 (0.32) | CPB2CPB1 | |
| SCHEMBL10883602 | 0.83 | CASP1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118085343-B | Preparation method of amino acid-based polypeptide hydrogel with antibacterial activity | 江苏惠利生物科技有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-118085343-A | Preparation method of amino acid-based polypeptide hydrogel with antibacterial activity | 江苏惠利生物科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-110684150-B | Amino acid nano hydrogel and preparation method and application thereof | 南方医科大学 | 2021-05-11 | — | — | CN | claimed |
| CN-110684150-A | Amino acid nano hydrogel and preparation method and application thereof | 南方医科大学 | 2020-01-14 | — | — | CN | claimed |
| EP-1190726-B1 | Liquefied embolic materials capable of sol-gel phase transition and their use | KWANGJU INST SCI & TECH (KR) | 2004-06-09 | — | — | EP | claimed |
| US-5851546-A | Polymer composition for controlled release of active ingredients in response to pH, and a process of preparing the same | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 1998-12-22 | — | — | US | claimed |
| US-5780578-A | Synthetic polymer exhibiting hydrolytic activity, its preparation and use for conversion of esters and amides to the corresponding alcohol and amine | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 1998-07-14 | — | — | US | claimed |
| US-5104729-A | PROCESS FOR SURFACE MODIFYING A SUPPORT MEMBRANE AND PRODUCT PRODUCED | MONSANTO COMPANY (US) | 1992-04-14 | — | — | US | claimed |
| EP-0474617-A1 | Process for surface modifying a support membrane | MONSANTO COMPANY (US) | 1992-03-11 | — | — | EP | claimed |
| US-12551442-B2 | Multifunctional microsphere preparation for chemoembolization therapy and imaging of tumors, and preparation method therefor | FUDAN UNIVERSITY (CN) | 2026-02-17 | — | — | US | disclosed |
| CN-119912927-A | Corrosion inhibitor for oilfield acidification and preparation method thereof | 东营江源化工有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-118085343-B | Preparation method of amino acid-based polypeptide hydrogel with antibacterial activity | 江苏惠利生物科技有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-114405545-B | Cellulose inscription mimic enzyme, construction method and application thereof | 河南科技大学 | 2024-06-07 | — | — | CN | disclosed |
| CN-118085343-A | Preparation method of amino acid-based polypeptide hydrogel with antibacterial activity | 江苏惠利生物科技有限公司 | 2024-05-28 | — | — | CN | disclosed |
| US-6562362-B1 | Copolymer of n-isopropylacrylamide and an ionic strength or pH sensitive monomer; nondegradable; side effects reduction | KWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2003-05-13 | — | — | US | disclosed |
| EP-1190726-A2 | Liquefied embolic materials capable of sol-gel phase transition and their use | Kwangju Institute of Science and Technology (KR) | 2002-03-27 | — | — | EP | disclosed |
| US-5851546-A | Polymer composition for controlled release of active ingredients in response to pH, and a process of preparing the same | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 1998-12-22 | — | — | US | disclosed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | disclosed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12551442-B2 | Multifunctional microsphere preparation for chemoembolization therapy and imaging of tumors, and preparation method therefor | MKI67, PCNA, APOB | TGM2 3486/4885GSTO1 715/4885TSHR 337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.